Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HNRNPLL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CITED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLG3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MTMR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EP300 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERBB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on